Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Biologic therapy. University of Colorado Denver, Aurora, CO, United States

Survival: 11.6 months
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: Aurora, CO
Hospital: University of Colorado Denver
Journal: Link
Date: 10/2011

This phase II study involved 54 women with previously treated epithelial ovarian cancer or primary peritoneal cancer. The median patient age was 62 years.

Patients were treated with the biologic therapy agent temsirolimus, which is an inhibitor of a protein involved in cancer cell growth called mTOR.

The most severe adverse events were grade 4 fatigue and pulmonary embolism. Grade 3 mucositis (inflammation of the GI tract) and dehydration were also reported.

The median overall survival was 11.6 months.

Correspondence: Dr. Kian Behbakht; email:

E-mail to a Friend Email Physician More Information